Advertisement
News
Advertisement

Iridex receives CE Mark and FDA nod for its laser delivery system

Mon, 12/10/2012 - 3:05pm
Mass Device

Iridex touts FDA and CE clearance for its TxCell scanning laser delivery system, a non-invasive device designed to treat serious retinal diseases.

Iridex logo

Mountain View, Calif.-based Iridex (NSDQ:IRIX) is celebrating twin regulatory wins for its laser system to treat serious retinal diseases.

The company said it landed FDA clearance in the U.S. and the CE Mark in the EU for its TxCell scanning laser delivery system, which would help physicians deliver the laser in a multi-spot scanning mode for the treatment of serious retinal diseases, according to a press release.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading